scispace - formally typeset
S

Selam Mihreteab

Publications -  4
Citations -  183

Selam Mihreteab is an academic researcher. The author has contributed to research in topics: Plasmodium falciparum & Malaria. The author has an hindex of 4, co-authored 4 publications receiving 127 citations.

Papers
More filters
Journal ArticleDOI

Major Threat to Malaria Control Programs by Plasmodium falciparum Lacking Histidine-Rich Protein 2, Eritrea.

TL;DR: In this paper, the authors investigated the HRP gene 2/3 status in 50 infected patients at 2 hospitals in Eritrea and found that 80.8% of patients at Ghindae Hospital and 41.7% at Massawa Hospital were infected with pfhrp2-negative parasites and 92.3% (24/26).
Journal ArticleDOI

Corrigendum to 'A novel multiplex qPCR assay for detection of Plasmodium falciparum with histidine-rich protein 2 and 3 (pfhrp2 and pfhrp3) deletions in polyclonal infections'.

TL;DR: A novel and rapid multiplex real time quantitative (qPCR) assay to detect p fhrp2, pfhrp3, confirmatory parasite and human reference genes simultaneously simultaneously is developed and validated and is easily scalable to routine surveillance studies in countries where P. falciparum parasites lacking pf hrp2 and pfHRp3 are a threat to malaria control.
Journal ArticleDOI

Gains attained in malaria control coverage within settings earmarked for pre-elimination: malaria indicator and prevalence surveys 2012, Eritrea.

TL;DR: The observed low malaria parasite prevalence could be associated with malaria intervention coverage, access and utilization as well as high and equitable knowledge levels in the population in Eritrea, indicating that Eritrea is on the right track towards pre-elimination.
Posted ContentDOI

A Novel Multiplex qPCR Assay for Detection of Plasmodium falciparum with Histidine-rich Protein 2 and 3 (pfhrp2 and pfhrp3) Deletions in Polyclonal Infections

TL;DR: A novel and rapid multiplex real time quantitative (qPCR) assay to detect p fhrp2, pfhrp3, confirmatory parasite and human reference genes simultaneously simultaneously is developed and validated and is easily scalable to routine surveillance studies in countries where P. falciparum parasites lacking pf hrp2 and pfHRp3 are a threat to malaria control.